Clazosentan
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
Molecular Identity
Clazosentan
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
PubChem CID: 6433095
2D Structure
Properties
C25H23N9O6S
Molecular Formula
577.60
Molecular Weight
g/mol
577.1492
Exact Mass
Da
1.6
XLogP
Drug-like (Lipinski: < 5)
208
TPSA
May have limited oral absorption
3
H-Bond Donors
14
H-Bond Acceptors
916
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Clazosentan180384-56-9VML-588AXV-034343Ro-61-1790AXV-343434Ro 61-1790PivlazVML 588ACT-108475AXV-034DTXSID601709553DRR0X4728N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamideN-(6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Clazosentan
Loading drug network...